跳至主要内容
临床试验/NCT01111409
NCT01111409已完成不适用

A Prospective, Multi-Centre Pilot Study to Evaluate the Clinical Effectiveness and Safety of the VFIX Device as Treatment for Apical Prolapse

Ethicon, Inc.3 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2010年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Ethicon, Inc.
入组人数
20
试验地点
3

研究概览

简要总结

The primary objective of this pilot study is to evaluate the safety and effectiveness of the VFIX device in maintaining vaginal apical support for at least 6 months in women with symptomatic apical prolapse (upper vaginal or uterine prolapse).

详细描述

Assuming success of the VFIX anatomical observational study (protocol 300-08-009), in this pilot study approximately 20 subjects (excluding the Device Run-In (DRI) subjects) will undergo the VFIX procedure to evaluate the safety and effectiveness of the VFIX device in maintaining apical support for at least 6 months, in women with symptomatic apical prolapse.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Age greater than or equal to 18 years
  • •Subjects of child bearing potential have a negative blood or urine pregnancy test prior to the procedure and subject has completed childbearing
  • •Subject with apical prolapse at stage II or more and requiring treatment (C should be at least -1 cm)
  • •On reduction of the apical prolapse, leading edge of prolapse should be at or above the hymen
  • •If applicable, subject has small/normal size uterus and there is no elongation of the cervix as determined by clinical assessment
  • •The vaginal apex can reach the Sacrospinous Ligament (SSL) on exam
  • •Subjects are allowed concurrent incontinence procedure as required
  • •Concurrent perineal repairs and excision of excess vaginal tissue repairs as required
  • •Agrees to participate in the study, including completion of all study-related procedures, evaluations and questionnaires, and documents this agreement by signing the Ethics Committee approved informed consent

排除标准

  • •Additional surgical intervention for POP repairs concurrent to the VFIX procedure (including, but not limited to sacrocolpopexy, paravaginal repair, colporrhaphy, mesh repair, etc)
  • •Experimental drug or experimental medical device within 3 months prior to the planned procedure
  • •Active genital, urinary or systemic infection at the time of the surgical procedure. Surgery may be delayed in such subjects until the infection is cleared.
  • •Previous hysterectomy within 6 months of scheduled surgery.
  • •Coagulation disorder or on therapeutic anticoagulant therapy (except aspirin) at the time of surgery
  • •Nursing or pregnant
  • •Presence of cancers of the vagina, cervix, or uterus
  • •In the investigator's opinion, any medical condition or psychiatric illness that could potentially be life threatening or affect their ability to complete the study visits according to this protocol

研究组 & 干预措施

VFIX

Experimental

干预措施: VFIX Device (Device)

研究者

发起方
Ethicon, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验